HETEROCYCLIC INHIBITORS OF RIP1 KINASE
VE6142020000145SUndetermined Publication Date: 2022-02-17RIGEL PHARMACEUTICALS INC
View PDF 0 Cites 0 Cited by
Patent Information
- Authority / Receiving Office
- VE · VE
- Patent Type
- Designs
- Current Assignee / Owner
- RIGEL PHARMACEUTICALS INC
- Filing Date
- 2020-09-24
- Publication Date
- 2022-02-17
Need to check novelty before this filing date? Find Prior Art
Description
This document discloses kinase inhibitor compounds, such as receptor-interacting protein 1 (RIP1) kinase inhibitors, as well as pharmaceutical compositions and combinations comprising such inhibitor compounds. The disclosed compounds, pharmaceutical compositions, and / or combinations may be used to treat or prevent a kinase-related disease or condition, particularly a RIP1-related disease or condition.